Jeremie Calais
Nuclear Imaging & Therapy · Los Angeles, CANPI 1053927079
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $98,976 of the $130,660 with a category attached, or 75.8%. 18 manufacturers reported payments, led by Telix Pharmaceuticals at 31.6% of the total. 2025 is the largest year on record at $39,012, more than ten times the $3,163 reported in 2020.
Across 74 payments — averaging $1765.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Telix Pharmaceuticals$41K
- Novartis$16K
- GE HealthCare$12K
- Astellas Pharma Global Development$11K
- Progenics Pharmaceuticals, Inc.$8K
- Sanofi$8K
- plus $33K from 12 others
Across 71 payments — averaging $177,860 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$12.1M
- Progenics Pharmaceuticals, Inc.$427K
- Eli Lilly$35K
- Janssen Research & Development, LLC$31K
- Novartis Pharma AG$2K
What the payments were for
- Consulting fees$98,97676%
- Speaking & faculty fees$23,13018%
- Travel & lodging$8831%
- Food & beverage$6721%
- Education$7,0005%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Telix Pharmaceuticals | 17 | $41,276 |
| Novartis | 12 | $16,259 |
| GE HealthCare | 10 | $12,196 |
| Astellas Pharma Global Development | 6 | $11,317 |
| Progenics Pharmaceuticals, Inc. | 7 | $8,298 |
| Sanofi | 2 | $7,887 |
| Janssen Global Services, LLC | 4 | $6,113 |
| Janssen Research & Development, LLC | 2 | $4,950 |
| Siemens Medical Solutions USA, Inc. | 2 | $4,700 |
| Blue Earth Diagnostics | 2 | $4,350 |
| Pfizer | 1 | $4,200 |
| Curium US LLC | 2 | $2,713 |
| Advanced Accelerator Applications | 2 | $2,163 |
| Bayer | 1 | $1,270 |
| Sumitomo Pharma Co., Ltd. | 1 | $1,100 |
| Cardinal Health 414 LLC | 1 | $720 |
| Amgen | 1 | $649 |
| Isoray, Inc | 1 | $500 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ILLUCCIX$46,000
- XTANDI$15,517
- JEVTANA$7,887
- PYLARIFY$7,848
- PLUVICTO$3,825
- 64Cu-PSMA-I&T$2,700
- 177Lu-PSMA-I&T$2,700
- POSLUMA$2,600
- Lutathera$2,500
- ZYTIGA$2,160
- Erleada$1,688
- Brachytherapy Source$500
How this compares
Too few nuclear imaging & therapy providers in Californiato place this figure against a meaningful peer group, so we don't.
Other nuclear imaging & therapy in Los Angeles
- John LinfootLafayette$4K
- Maria GuevaraNorth Hollywood$2K
- Holly Marciniak ThompsonSanta Clara$391
- Frederick WeilandRoseville$332
- Chiayi NiSylmar$210
- Ryan ReddyIrvine$208
- Jocelyn EspirituModesto$127
- Evelyn MusniFremont$114
- John WhiteRancho Palos Verdes$34
- Eugene SilvermanSan Diego$20
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.